ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Overview Fund Activity
Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

143 hedge funds and large institutions have $353M invested in Intercept Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 60 increasing their positions, 39 reducing their positions, and 31 closing their positions.

Holders
143
Holders Change
-12
Holders Change %
-7.74%
% of All Funds
2.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
60
Reduced
39
Closed
31
Calls
$14.7M
Puts
$13.3M
Net Calls
+$1.46M
Net Calls Change
-$19.8M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$45M
2
ECM
2
ExodusPoint Capital Management
New York
$6.56M
3
GPP
3
Great Point Partners
Connecticut
$6.54M
4
Nuveen Asset Management
4
Nuveen Asset Management
Illinois
$9.87M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$4.5M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$2.06M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$547K
3
Jane Street
3
Jane Street
New York
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$1.3M
5
SG Americas Securities
5
SG Americas Securities
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$45M 3,637,935 +931,521 +34%
State Street
2
State Street
Massachusetts
$39.3M 3,175,925 +124,341 +4%
BlackRock
3
BlackRock
New York
$38.2M 3,084,833 +148,646 +5%
Millennium Management
4
Millennium Management
New York
$12.1M 976,706 -201,043 -17%
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$11.4M 923,107 +142,162 +18%
EAM
6
Eventide Asset Management
Massachusetts
$9.9M 800,000 – –
Nuveen Asset Management
7
Nuveen Asset Management
Illinois
$9.87M 797,910 +385,884 +94%
Morgan Stanley
8
Morgan Stanley
New York
$9.55M 772,380 -125,593 -14%
Renaissance Technologies
9
Renaissance Technologies
New York
$8.76M 708,300 -30,900 -4%
Macquarie Group
10
Macquarie Group
Australia
$8.31M 671,995 +16,055 +2%
SB
11
Samsara BioCapital
California
$7.93M 640,688 – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$7.24M 584,994 +137,216 +31%
Rockefeller Capital Management
13
Rockefeller Capital Management
New York
$6.99M 565,185 +28,421 +5%
Goldman Sachs
14
Goldman Sachs
New York
$6.81M 550,239 +177,773 +48%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$6.75M 545,400 -86,700 -14%
ECM
16
ExodusPoint Capital Management
New York
$6.56M 530,567 +446,628 +532%
GPP
17
Great Point Partners
Connecticut
$6.54M 528,850 +423,850 +404%
Bank of America
18
Bank of America
North Carolina
$6.53M 527,689 +84,526 +19%
Citadel Advisors
19
Citadel Advisors
Florida
$5.9M 477,129 +114,068 +31%
JAM
20
Jupiter Asset Management
United Kingdom
$5.22M 421,595 +78,954 +23%
JPMorgan Chase & Co
21
JPMorgan Chase & Co
New York
$4.91M 396,803 +222,952 +128%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$4.84M 391,853 +291,417 +290%
Citigroup
23
Citigroup
New York
$4.66M 376,647 +59,720 +19%
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$4.5M 364,068 +336,332 +1,213%
Charles Schwab
25
Charles Schwab
California
$3.44M 277,708 +115,573 +71%
1
2 3 4 5